chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; Vaccine administered after beeing in the fridge for 40 days; Vaccine administered after beeing in the fridge for 40 days; This spontaneous case was reported by a nurse and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PRODUCT STORAGE ERROR (Vaccine administered after beeing in the fridge for 40 days) and EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beeing in the fridge for 40 days) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040C21A, 029L20A and 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Hypertension, Hypothyroidism, Hyperlipidemia and Immunocompromised. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) and LOSARTAN for an unknown indication.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PRODUCT STORAGE ERROR (Vaccine administered after beeing in the fridge for 40 days) and EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beeing in the fridge for 40 days). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown and PRODUCT STORAGE ERROR (Vaccine administered after beeing in the fridge for 40 days) and EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beeing in the fridge for 40 days) had resolved.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-304556 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up received on 31-Aug-2021 and date of birth is updated. On 09-Sep-2021: Significant follow up received on 09 SEP 2021, patient demographics updated, concomitants updated, 1st and 2nd dose details updated.
ADMINISTERED A DOSE OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 57 year old male. The patient's weight was 85 kilograms, and height was not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, administered on 28-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 28-SEP-2021, the patient experienced administered a dose of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administered a dose of expired vaccine was not reported. This report was non-serious.
seen 29JAN93 @ clinic c/o sore arm pain radiating up arm to neck; told hit a nerver during shot; rx for Orudis & APAP codeine; seen 1FEB93 same clinic by NP;
Myalgia, Arthralgia, NauseaVomiting, fatigue, arm pain x 48hrs Narrative:
Mild dull headache began  about 18 hours post-vax.   Unresponsive to OTC pain relief.   About 5 hours later, there was an episode of chills, accompanied by severe shaking.  Face and neck became very warm and flushed.  After about an hour, the episode ended, and even the long-lasting headache felt better.  Have not had any adverse effects that were not known to be occurring in some after the 2nd Pfizer vax.
Cold sore; Itching; A slight allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (A slight allergic reaction), ORAL HERPES (Cold sore) and VACCINATION SITE PRURITUS (Itching) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced HYPERSENSITIVITY (A slight allergic reaction) and VACCINATION SITE PRURITUS (Itching). On 21-Feb-2021, the patient experienced ORAL HERPES (Cold sore). The patient was treated with VALACYCLOVIR [VALACICLOVIR] for Cold sores, at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (A slight allergic reaction) and VACCINATION SITE PRURITUS (Itching) had resolved and ORAL HERPES (Cold sore) outcome was unknown.            Concomitant medication was not provided.
Information has been received from a physician referring to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of improperly stored MMR II (lot # K016154, expiration date 24-SEP-2016, subcutaneous). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
17 yo previously healthy male that seen in clinic  Friday 8/27/2021 for sports physical.  Only complaint with right ear pain that was previously diagnosed as otitis media in after hours clinic.  Still with symptoms.  On exam large right lymph node, hard, nontender, nonmobile right angle of jaw.  Additional left superior anterior SCM 8 cm lymph node with similar description.  WBC 50K. Patient sent to Hospital ER and currently admitted and diagnosed with AML. He is undergoing bone marrow transplant and 6 weeks of chemotherapy.
swollen, infected lymph node. Took antibiotics and the symptoms disappeared with in 5 days.
Patient received 2nd Pfizer shot 2 weeks after the first shot instead of 3 weeks after (1st shot was on 5/19/21).
85-year-old male, resident of boarding care facility, history of diastolic heart failure, benign neoplasm of the pituitary gland, history of gastrointestinal stromal tumor/stomach cancer, GERD with esophageal stricture, previous lacunar infarct, HLD, male hypogonadism failure on long-term testosterone, who presented from skilled nursing facility on 02/01 due to change in mental status along with fever.  Although he tested negative for COVID at the boarding care facility, he tested positive in the ED 02/01.  No further information it is revealed that his roommate was positive.  Onset of his own symptoms was not clear.  He was noted to have elevation of transaminases but no hypoxemia.  Hence he was started on remdesivir but not steroid.  Ultrasound of his right upper quadrant revealed the presence of cholelithiasis which were previously known without thickening of the gallbladder wall but they were unable to assess for Murphy sign sonographically.  Clinically he did not not meet criteria for cholecystitis.  Transaminase elevation improved significantly.  His mental status also improved dramatically within 24 hours.
Angioedema (both eyes swollen shut) took medication prescribed by primary care physician; resolved inn48 hours
Information has been received from a certified medical assistant concerning a male with no pertinent medical history or allergies who in approximately 1999 (1 year of age) was vaccine subcutaneous with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. At a recent office visit it was mentioned the patient developed breakthrough chickenpox at an unspecified date. No diagnostic labs were performed. Subsequently, the patient recovered from breakthrough chickenpox. A product quality complaint was not involved. Additional information has been requested.
Arm pain immediately afterwards. Beginning at 18 hours after vaccination: excruciating headache, nausea, diarrhea, elevated temperature/flushing, chills, fatigue, swelling and redness at injection site.  Unable to eat or drink anything for 12 hours.  Symptoms started to ameliorate after taking 1,000mg of acetaminophen  around 28 hours after injection.   48 hours after vaccination, most symptoms had passed except for some residual headache and fatigue.  Short fainting spell at 49 hours but did not pass out.
Noticed higher blood pressure and heart rate substantially increased after booster (it slowly increased after second vax). I had been taking BP 2x/week since 11/12. Had doc appt on 12/13/21. Given Losartan rx, but didn't want to take. My BP on 12/31/21 was 176/110 with heart rate of 94. Decided to start taking Losartan. On 1/1/22 it was 156/100 with pulse of 86. On 1/4/22 is was 122/80 with pulse of 80. On 1/6/22 it was 144/90 with pulse of 94. Today it is 150/94 with pulse of 71. (I did forget to take the med yesterday.)
Have had eczema mu whole life, but have had it under control since moving nine years ago. Shortly after receiving  the Fluzone High-Dose Quad (09/13/2021), various skin conditions occurred that had never happened before. Skin bumps and  lesions to my face. Plaque psoriasis to my scalp, neck and forehead.  Severe redness to my forehead and hands. Skin abscess (boil) in my left groin area that burst and bled and made walking difficult
Pt started with small hives early on 10/31/2018 and during the day the pt started to have systemic hives. Patient only had exposure to deodorant with no reaction to application site. Pt presented to the clinic today with systemic hives as well as a "tightness" in his throat.
swollen, itcy, feverish upper arm located at injection site of vaccination . Started swelling yesterday early morning,  felt hot, feverish and itchy - continuing through today
I was 5 weeks pregnant when I had the mercury-free flu shot. At 7 weeks pregnant, an ultrsound found no fetal heartbeat and the fetus measured 5 weeks pregnant. Doctor confirmed miscarriage of pregnancy.
Moderna vaccine expiration date 4/24/2022.  Date administered 4/25/2022 was 1 day past expiration date.  Arm sore and achy.  No other symptoms noted.
Myalgia, Arthralgia, chills, fatigue, left elbow & left knee, right ankle pain Narrative:  Seen by facility for left elbow & left knee, right ankle pain. Taking NSAIDS "around the clock" for relief of pain at these sites.   Other Relevant History:
I experienced a breakthrough case of COVID-19 with fever, shakes, chills, headaches, vomiting, nausea, horrible sinus headache, tons of congestion, mucus, coughing and no appetite.
This case was reported by a physician via a general injectables and vaccines wholesaler and described the occurrence of shoulder pain in a 38-year-old female subject who was vaccinated with (FLULAVAL, GlaxoSmithKline). In 2008 the subject received unspecified dose of FLULAVAL (unknown).  In 2008, at an unspecified time after vaccination with FLULAVAL, the subject experienced left shoulder pain, neck pain and was unable to move arm at the shoulder.  At the time of reporting the outcome of the events was unspecified.
Broke out around 3:30 PM. Red, raised, spots from waist down on front of body and waist down on back of body. Warm to touch. Mom relates she gave him a luke warm bath. No soap. Only water. Child taken to provider on 05-10-2016 as rash spread to chin. Provider said rash is probably a delayed reaction to Amoxicillin that he is on. Per mom provider said, "if this were my son, I'd keep on it." Follow up with provider on Wednesday, May 18, 2016.
7:20 AM instantaneously vomiting while driving vehicle, cold/hot, HIGH PULSE rate, HBP, Blood Sugar (unknown-no batteries), SVT, Low Grade Fever, Chills, restless, high abdominal bloating, overall Body Aches and severe lethargy...now 12:51 PM small-amount watery diarrhea, nausea, HBP, restless, all previous symptoms listed, cannot sleep/rest, am able to keep down sips of liquids at a time (from vomiting).
1840 NSG staff notified that resident had fallen and was unable to get up. Upon arrival to resident, resident was lying on her right side outside of her room. Resident was severely diaphoretic and unable to state what had occurred. Resident had a blue tinge to her lips, wheezing bilaterally, equal strength bilaterally and very weak. BP 143/74, HR 66, 02 80%, temperature unable to read temporally due to diaphoresis. respirations equal and labored at 22 breaths per minute. EMS called. RN and CNA staff stayed with resident while waiting for arrival of EMS. During this time, son called resident's phone and he was updated of the situation. Upon EMS arrival at 1700, resident was regaining orientation and was no longer diaphoretic. EMS bs was 143. 02 placed on resident by EMS with 12 lead to be done on transport. EMS left with resident at approximately 1907. SJH ED called and given report to RN. DON notified.
weak/"savvy"; not able to do those activities; legs felt super weak; and unsteady; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (legs felt super weak), GAIT DISTURBANCE (and unsteady), ASTHENIA (weak/"savvy") and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (not able to do those activities) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939905, 008B21A and 044B21A) for COVID-19 vaccination.     Concomitant products included METFORMIN, HYDROCHLOROTHIAZIDE and METOPROLOL for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Nov-2021, the patient experienced MUSCULAR WEAKNESS (legs felt super weak) and GAIT DISTURBANCE (and unsteady). On an unknown date, the patient experienced ASTHENIA (weak/"savvy") and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (not able to do those activities). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at a dose of 1 UNK. On 30-Nov-2021, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (not able to do those activities) had resolved. At the time of the report, MUSCULAR WEAKNESS (legs felt super weak), GAIT DISTURBANCE (and unsteady) and ASTHENIA (weak/"savvy") outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Consumer stated on 06Nov2021 she started she had side effects after getting a booster dose on 03Nov2021. Consumer stated on 06Nov2021 her legs felt super wear and unsteady. It continued to be like than but seem like it was getting better. Sometimes she felt weak and savvy. She also added she felt better on somedays and then on somedays she did not, with AEs reported above. Consumer stated she was physically active and was not able to do those activities. But she was able to do her activities on 30Nov2021   This case was linked to MOD-2021-402868, MOD-2021-402797 (Patient Link).
Breakthrough COVID infection. Pt fully vaccinated on feb 6 2021. Positive covid test 10/13/2021
I was admitted to the hospital on Fri 20Aug2021 to Sat 21Aug2021 for myopericarditis. I got my third dose of the Pfizer Covid vaccine on Monday 16Aug (5 months after my second shot) and this precipitated an overreactive immune response. I have autoimmune disease called mixed connective tissue disease in which my flares typically present as autoimmune pericarditis. Whether this instance of myopericarditis was a true flare, a side effect of the vaccine, or both is still undetermined. Symptoms were shortness of breath upon light exertion, chest pain upon inspiration, fatigue, chest tightness.  I got labs done Friday morning upon the request of Dr. and my CRP and troponin I levels were elevated, so he suggested I start Prednisone immediately and go to the ER. My troponin continued to rise slightly during the night, but then started to decline. I was discharged Saturday 21Aug2021 evening.
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live follow up received contains narrative updated.
Swelling, redness, skin warm to touch, itchy bicep area radiating from injection site. Treated with oral BENADRYL, amoxicillin, ice packs.
Diarrhea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (Diarrhea) and VOMITING (Vomiting) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history was provided by the reporter.  Concomitant products included ALECTINIB HYDROCHLORIDE (ALECENSA) for an unknown indication.    On 02-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced DIARRHEA (Diarrhea) and VOMITING (Vomiting). At the time of the report, DIARRHEA (Diarrhea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment information was not provided.
Tightness in the back of both knees; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Tightness in the back of both knees) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020-821A) for COVID-19 vaccination.     Concurrent medical conditions included Varicose veins. Concomitant products included ATENOLOL for Blood pressure abnormal, OMEPRAZOLE for Gastric acid increased, Albuterol and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 29-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced JOINT STIFFNESS (Tightness in the back of both knees). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, JOINT STIFFNESS (Tightness in the back of both knees) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Right hand pain/index finger swollen and very stiff/painful in joints in right hand/hurt to move fingers.  Migrating redness on right hand. Middle finger to hand.
hair started falling out again like it did first shot; Numbness in both arms; ringing in ears(still have); fever 102; swollen lymph nodes; sever pain in arm that lasted for 3 months after shot; sickness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21Apr2021 (Lot number: Ew0170) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Anatomical Location: Arm left, Batch/lot number: Er8732), administration date: 23Mar2021, when the patient was 46 years old, for Covid-19 Immunisation, reaction(s): "hair started falling out", "Numbness in both arms", "ringing in ears(still have)", "sever pain in arm", "swollen lymph nodes". The following information was reported: ALOPECIA (non-serious) with onset 2021, outcome "recovering", described as "hair started falling out again like it did first shot"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "recovering", described as "Numbness in both arms"; TINNITUS (non-serious) with onset 2021, outcome "recovering", described as "ringing in ears(still have)"; PYREXIA (non-serious) with onset 2021, outcome "recovering", described as "fever 102"; LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovering", described as "swollen lymph nodes"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovering", described as "sever pain in arm that lasted for 3 months after shot"; ILLNESS (non-serious) with onset 2021, outcome "recovering", described as "sickness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of alopecia, hypoaesthesia, tinnitus, pyrexia, lymphadenopathy, pain in extremity, illness.  Additional information: Patient was not pregnant at the time of vaccination. Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Numbness in both arms that lasted about 3 months, hair started falling out again like it did first shot. Fever 102 for 24 hrs, ringing in ears(still have),swollen lymph nodes, sever pain in arm that lasted for 3 months after shot. Patient missed 5 days of work the second shot due to sickness after. Patient cried in pain for 2 days from body pain and fever. Patient's hair was still recovering. Therapeutic measures taken for the event included Chiropractor & getting messages, and salt float ta. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.